Liquidia Corporation
NASDAQ:LQDA · NASDAQ Capital Market
+$0.23 today
Vol 12.43M · Avg 1.50M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+435.97%
Period High
$71.80
Period Low
$12.00
Latest
$71.07
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
ImmunityBio, Inc.
NASDAQ:IBRX
$7.48B
Cogent Biosciences, Inc.
NASDAQ:COGT
$5.90B
Denali Therapeutics Inc.
NASDAQ:DNLI
$3.81B
Structure Therapeutics Inc.
NASDAQ:GPCR
$2.64B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.47B
89bio, Inc.
ETNB
$2.20B
Ocular Therapeutix, Inc.
NASDAQ:OCUL
$2.17B
Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
$2.03B
Mesoblast Limited
NASDAQ:MESO
$1.88B
Galapagos N.V.
GLPG
$1.84B
What is the latest LQDA filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does LQDA have?
Intrinsic Alpha currently shows 20 recent filings for LQDA.
Explore More
Continue the stock analysis
Jump to another research area for this company.